Share Prices & Company Research

Market News

12 Nov 2018 | 13:43

Avacta to present pre-clinical development data at Lisbon conference

Biotherapeutics and reagents developer Avacta Group said chief scientific officer Amrik Basran would present at a conference in Lisbon this week.

Basran would on Wednesday present recent data from pre-clinical development of the company's lead therapeutic programme, at the Protein Engineering Society of Europe meeting.

Avacta said it was developing a single-molecule bi-specific therapy with a view to entering phase I clinical development in 2020.

At 1:43pm: (LON:AVCT) Avacta Group PLC share price was 0p at 24.1p

Story provided by
Get in touch today
Join Redmayne Bentley
Talk to us now about opening a new account or transferring your account from another provider
0113 243 6941
Get in touch today
Contact your local office
Contact your local office to find out more
The value of your investments and the income from them may go down as well as up, and you could get back less than you invested.
We use cookies on this site to improve your experience and help us provide you with a better website. An explanation of the cookies we use and their purpose can be found within our Cookie Policy. Your continued use of this site means you consent to the use of cookies.